Cheap drug can save thousands of babies
Government was yesterday presented with evidence that it could save the lives of thousands of babies cheaply and effectively by giving their HIV positive mothers the drug Nevirapine during labour.
The drug could cut the rate of HIV transmission from mother to child by about one third, meaning that only about 7% of babies born to HIV positive women would be infected at birth.
At present, some 60 000 HIV positive babies are born each year in South Africa. Yet most could be saved for R21 – the cost of one tablet for a mother in labour plus another for her and her baby soon after.
“This is compelling data. It works, it’s easy to implement and it’s cheap,” said Dr Glenda Gray, head of the Chris Hani Baragwanath’s perinatal HIV unit, and part of the drug trial.
The results of the 10-month study – in which Nevirapine was tested against AZT — have not yet been written up, but the Department of Health was given the speakers’ notes yesterday.
“The department of health has been receptive and open to our study,” said Gray, describing the HIV epidemic amongst children in this country as “overwhelming and explosive”. About 5 000 HIV positive babies are born each month.
Health department director general Ayanda Ntsaluba said that once he had the written report, his department could study it and then meet the researchers and discuss the matter further.
“But to think we can just wake up in the morning and give Nevirapine is just not possible,” said Ntsaluba.
Gray said the main barrier to implementation nationally was the lack of facilities to test the HIV status of pregnant women.
The study of over 1 300 women found that 28 doses of AZT had to be given in order to be as effective as Nevirapine.
Dr James McIntyre, co-head of the study, said that although four mothers and 17 babies had died, none of these deaths were related to the drugs.
Co-head Dr Daya Moodley said babies’ infection depended on how much HIV their mothers had in their bodies, but warned babies who were breastfed after birth were at much greater risk of getting HIV in the first six months of their lives than those who were bottlefed.
Government has been under great pressure to provide anti-retrovirals to pregnant HIV positive mothers, as some 60 000 HIV positive babies are born in the country every year. However, in the past government has said that anti-retrovirals are too expensive.
In addition, government officials have pointed out that even if these babies were saved their quality of live would be compromised as they were destined to be orphans.
The Treatment Action Group has said that it is immoral to save babies without giving anti-retroviral drugs to their mothers.
“I am tired of hearing about orphans when their parents can be saved by anti-retroviral drugs,” said the TAC’s Zackie Achmat. – Health-e News Service.
Author
-
Kerry Cullinan is the Managing Editor at Health-e News Service. Follow her on Twitter @kerrycullinan11
View all posts
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Cheap drug can save thousands of babies
by Kerry Cullinan, Health-e News
July 12, 2000